GUANGZHOU YOU-HAO HOSPITAL ONCOLOGY CENTRE 

廣州友好醫院腫瘤综合治療中心

Home       About Us       Treated cases   Treatments offered       About PET/CT       FAQ       Contact Us     

Treatments Offered.

1.CEC (Cancer Emboli Cleavage)

2.Brachytherapy/Internal Gamma Knife

3.Targeted Chemotherapy (X3)

4.Biotherapy (Stem Cell Therapy)

5HIFU (High Intensity Focus Ultrasound .)

6.PDT (Photo Dynamic Treatment)

This is one of the most promising new approaches to cancer prevention and treatment and

offers great hope to cancer sufferers.

Biotherapy is a therapy for anti-cancer, prevention of disease and anti-ageing.

What is cancer biotherapy? What are its advantages?

It is a treatment which uses the body’s own immune system to fight cancer.

This therapy stabilizes and balances the body’s anti-cancer response by regulating certain aspects of  the

natural anti-cancer mechanism of the body resulting in greater cancer prevention and treatment.

This therapy has none of the toxic side-effects which result from the use of conventional treatments like

radiotherapy and chemotherapy and does not inhibit hemopoiesis – the formation of blood cells in the body.

Instead it enhances the body’s immune response.

Treatment Principle

The aim of the treatment is to increase the quantity of T cells which

is a major factor in the body’s defense against cancer and also to

strengthen the killing function of the T cells. In other words, it is reinforcing

the anti-cancer army of the body and equipping it with more combative power.

What is the clinical effect of cancer biotherapy?

1) Biotherapy can increase the 5 years and 9 years survival rate for pulmonary cancer.

The treatment results of 174 postoperative primary pulmonary

cancer patients from the Medical College of Japanese Chiba University were:

2) Biotherapy can prevent the reoccurrence of liver cancer after operation.

Shanghai Liver Cancer Research Institute adopted the use of biotherapy

for the prevention of postoperative recurrence of liver

cancer in 41 patients. The results were:

The one year recurence rate in the routine therapy group was 17.1 % whereas

the one year recurence rate in the biotherapy group was only 2.4 %, a very obvious difference.

3) Biotherapy can prolong the survival term of patients with encephaloma.

Wuhan Tongji Hospital adopted the use of biotherapy for the prevention of

postoperative recurrence of brain glioma.  The results were:

The biotherapy group (19 cases)        Median survival time 38 months

The routine therapy group (20 cases) Median survival time 13 months.